278 related articles for article (PubMed ID: 15677479)
1. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
2. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
[TBL] [Abstract][Full Text] [Related]
3. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
5. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
Ding SY; Tribble ND; Kraft CA; Markwardt M; Gloyn AL; Rizzo MA
Mol Endocrinol; 2010 Jan; 24(1):171-7. PubMed ID: 19934346
[TBL] [Abstract][Full Text] [Related]
7. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
8. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
Gloyn AL; Noordam K; Willemsen MA; Ellard S; Lam WW; Campbell IW; Midgley P; Shiota C; Buettger C; Magnuson MA; Matschinsky FM; Hattersley AT
Diabetes; 2003 Sep; 52(9):2433-40. PubMed ID: 12941786
[TBL] [Abstract][Full Text] [Related]
9. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
[TBL] [Abstract][Full Text] [Related]
10. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
Beer NL; van de Bunt M; Colclough K; Lukacs C; Arundel P; Chik CL; Grimsby J; Ellard S; Gloyn AL
J Biol Chem; 2011 May; 286(21):19118-26. PubMed ID: 21454522
[TBL] [Abstract][Full Text] [Related]
12. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
13. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
Shen Y; Cai M; Liang H; Wang H; Weng J
Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type.
Ralph EC; Sun S
Biochemistry; 2009 Mar; 48(11):2514-21. PubMed ID: 19187021
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
[TBL] [Abstract][Full Text] [Related]
17. Glucokinase gene mutations (MODY 2) in Asian Indians.
Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase.
Gutierrez-Nogués A; García-Herrero CM; Oriola J; Vincent O; Navas MA
Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2385-2394. PubMed ID: 29704611
[TBL] [Abstract][Full Text] [Related]
19. Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.
Arden C; Trainer A; de la Iglesia N; Scougall KT; Gloyn AL; Lange AJ; Shaw JA; Matschinsky FM; Agius L
Diabetes; 2007 Jul; 56(7):1773-82. PubMed ID: 17389332
[TBL] [Abstract][Full Text] [Related]
20. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]